Medicine (United States), ISSN 0025-7974, 2016, Volume 95, Issue 41, p. e5137
Background:Movement disorder emergencies include any movement disorder which develops over hours to days, in which failure to appropriately diagnose and manage...
Anticholinergics | Haloperidol | Acute drug-induced dystonia | Benzodiazepines | haloperidol | MOVEMENT-DISORDER EMERGENCIES | MEDICINE, GENERAL & INTERNAL | acute drug-induced dystonia | benzodiazepines | anticholinergics | Dystonia - therapy | Dystonia - chemically induced | Diagnosis, Differential | Dystonia - diagnosis | Emergency Service, Hospital | Humans | Middle Aged | Emergencies | Adult | Female | Male | Disease Management
Anticholinergics | Haloperidol | Acute drug-induced dystonia | Benzodiazepines | haloperidol | MOVEMENT-DISORDER EMERGENCIES | MEDICINE, GENERAL & INTERNAL | acute drug-induced dystonia | benzodiazepines | anticholinergics | Dystonia - therapy | Dystonia - chemically induced | Diagnosis, Differential | Dystonia - diagnosis | Emergency Service, Hospital | Humans | Middle Aged | Emergencies | Adult | Female | Male | Disease Management
Journal Article
Parkinsonism and Related Disorders, ISSN 1353-8020, 2016, Volume 36, pp. 3 - 9
Abstract Oculogyric crisis (OGC) describes the clinical phenomenon of sustained dystonic, conjugate and typically upward deviation of the eyes lasting from...
Neurology | Drug-induced dystonia | Acute dystonic reaction | Dystonia | Oculogyric crisis | SEPIAPTERIN REDUCTASE DEFICIENCY | ONSET PARKINSONISM | BASAL GANGLIA | TYROSINE-HYDROXYLASE DEFICIENCY | ACID DECARBOXYLASE DEFICIENCY | CLINICAL NEUROLOGY | MOVEMENT-DISORDERS | VESICULAR TRANSPORT DISEASE | TARDIVE-DYSKINESIA | DOPA-RESPONSIVE DYSTONIA | PARKINSONS-DISEASE | Dystonia - chemically induced | Dystonia - diagnosis | Dyskinesia, Drug-Induced - physiopathology | Ocular Motility Disorders - diagnosis | Dopamine Antagonists - adverse effects | Humans | Ocular Motility Disorders - chemically induced | Dystonia - physiopathology | Ocular Motility Disorders - physiopathology | Antidepressive Agents - adverse effects | Dyskinesia, Drug-Induced - diagnosis | Development and progression | Brain damage | Neurosciences | Parkinson's disease | Health aspects
Neurology | Drug-induced dystonia | Acute dystonic reaction | Dystonia | Oculogyric crisis | SEPIAPTERIN REDUCTASE DEFICIENCY | ONSET PARKINSONISM | BASAL GANGLIA | TYROSINE-HYDROXYLASE DEFICIENCY | ACID DECARBOXYLASE DEFICIENCY | CLINICAL NEUROLOGY | MOVEMENT-DISORDERS | VESICULAR TRANSPORT DISEASE | TARDIVE-DYSKINESIA | DOPA-RESPONSIVE DYSTONIA | PARKINSONS-DISEASE | Dystonia - chemically induced | Dystonia - diagnosis | Dyskinesia, Drug-Induced - physiopathology | Ocular Motility Disorders - diagnosis | Dopamine Antagonists - adverse effects | Humans | Ocular Motility Disorders - chemically induced | Dystonia - physiopathology | Ocular Motility Disorders - physiopathology | Antidepressive Agents - adverse effects | Dyskinesia, Drug-Induced - diagnosis | Development and progression | Brain damage | Neurosciences | Parkinson's disease | Health aspects
Journal Article
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 04/2007, Volume 27, Issue 2, pp. 206 - 207
PSYCHIATRY | PHARMACOLOGY & PHARMACY | Dystonia - chemically induced | Acute Disease | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Piperazines - therapeutic use | Thiazoles - therapeutic use | Bipolar Disorder - drug therapy | Piperazines - adverse effects | Thiazoles - adverse effects | Laryngeal Diseases - chemically induced | Antipsychotic Agents - therapeutic use | Adult
Journal Article
Neuro-Ophthalmology Japan, ISSN 0289-7024, 2003, Volume 20, Issue 1, pp. 43 - 48
Journal Article
5.
Full Text
Antipsychotic drug-induced acute laryngeal dystonia: two case reports and a mini review
Journal of Psychopharmacology, ISSN 0269-8811, 05/2005, Volume 19, Issue 3, pp. 307 - 311
Antipsychotic-induced laryngeal dystonia is a life-threatening side-effect of both high- and low-potency classical antipsychotics, and its diagnosis often...
Antipsychotic-induced laryngeal dystonia | Antipsychotic side-effects | Thioridazine | Acute laryngeal dystonia | antipsychotic-induced laryngeal dystonia | PHARYNGEAL DYSTONIA | SUDDEN-DEATH | PSYCHIATRY | SCHIZOPHRENIA | RISPERIDONE | antipsychotic side-effects | NEUROSCIENCES | CLINICAL NEUROLOGY | thioridazine | COSTS | PRESCRIPTION PATTERNS | HALOPERIDOL TREATMENT | NEUROLEPTICS | PHARMACOLOGY & PHARMACY | PATIENT | TARDIVE-DYSKINESIA | acute laryngeal dystonia | Dystonia - chemically induced | Diagnosis, Differential | Laryngeal Diseases - diagnosis | Psychotic Disorders - complications | Antipsychotic Agents - adverse effects | Humans | Risk Factors | Haloperidol - therapeutic use | Male | Schizophrenia - complications | Haloperidol - adverse effects | Dystonia - diagnosis | Laryngeal Diseases - chemically induced | Antipsychotic Agents - therapeutic use | Adult | Female | Psychotic Disorders - drug therapy | Schizophrenia - drug therapy | Causes of | Complications and side effects | Antipsychotic drugs | Research | Diphtheria
Antipsychotic-induced laryngeal dystonia | Antipsychotic side-effects | Thioridazine | Acute laryngeal dystonia | antipsychotic-induced laryngeal dystonia | PHARYNGEAL DYSTONIA | SUDDEN-DEATH | PSYCHIATRY | SCHIZOPHRENIA | RISPERIDONE | antipsychotic side-effects | NEUROSCIENCES | CLINICAL NEUROLOGY | thioridazine | COSTS | PRESCRIPTION PATTERNS | HALOPERIDOL TREATMENT | NEUROLEPTICS | PHARMACOLOGY & PHARMACY | PATIENT | TARDIVE-DYSKINESIA | acute laryngeal dystonia | Dystonia - chemically induced | Diagnosis, Differential | Laryngeal Diseases - diagnosis | Psychotic Disorders - complications | Antipsychotic Agents - adverse effects | Humans | Risk Factors | Haloperidol - therapeutic use | Male | Schizophrenia - complications | Haloperidol - adverse effects | Dystonia - diagnosis | Laryngeal Diseases - chemically induced | Antipsychotic Agents - therapeutic use | Adult | Female | Psychotic Disorders - drug therapy | Schizophrenia - drug therapy | Causes of | Complications and side effects | Antipsychotic drugs | Research | Diphtheria
Journal Article
Seminars in Neurology, ISSN 0271-8235, 02/2019, Volume 39, Issue 1, pp. 125 - 136
Abstract Many acute and potentially life-threatening medical conditions have hyperkinetic or hypokinetic movement disorders as their hallmark. Here we review...
Review Article | serotonin syndrome | acute Parkinsonism | neuroleptic malignant syndrome | antipsychotics | malignant catatonia | drug-induced dystonia | Parkinsonism hyperpyrexia | acute dystonic reaction | oculogyric crisis | tardive dyskinesia | STATUS DYSTONICUS | SYDENHAMS CHOREA | CLINICAL NEUROLOGY | CATATONIA | SEROTONIN TOXICITY | INTERNATIONAL CONSENSUS | HEMICHOREA | DIAGNOSTIC-CRITERIA | WITHDRAWAL | PARKINSONS-DISEASE
Review Article | serotonin syndrome | acute Parkinsonism | neuroleptic malignant syndrome | antipsychotics | malignant catatonia | drug-induced dystonia | Parkinsonism hyperpyrexia | acute dystonic reaction | oculogyric crisis | tardive dyskinesia | STATUS DYSTONICUS | SYDENHAMS CHOREA | CLINICAL NEUROLOGY | CATATONIA | SEROTONIN TOXICITY | INTERNATIONAL CONSENSUS | HEMICHOREA | DIAGNOSTIC-CRITERIA | WITHDRAWAL | PARKINSONS-DISEASE
Journal Article
International Journal of Risk and Safety in Medicine, ISSN 0924-6479, 2010, Volume 22, Issue 2, pp. 111 - 114
Journal Article
Neuropsychiatric Disease and Treatment, ISSN 1176-6328, 02/2016, Volume 12, pp. 497 - 499
Tetrabenazine is used in the treatment of chorea, tardive dyskinesia, tics, and dystonia. It rarely causes acute eyeball dystonia and the description of this...
Drug-induced dystonia | Eyeball dystonia | Dystonic tics | Tic disorder | Acute dyskinesia | Tetrabenazine-induced side effects | DRUG | tic disorder | PSYCHIATRY | eyeball dystonia | dystonic tics | acute dyskinesia | drug-induced dystonia | tetrabenazine-induced side effects | CLINICAL NEUROLOGY | Tourette's syndrome | Neurology | Encephalitis | Jaw | Young adults | Dopamine | Comorbidity | Pathogenesis | Tourette syndrome | Patients | Drug dosages | Age
Drug-induced dystonia | Eyeball dystonia | Dystonic tics | Tic disorder | Acute dyskinesia | Tetrabenazine-induced side effects | DRUG | tic disorder | PSYCHIATRY | eyeball dystonia | dystonic tics | acute dyskinesia | drug-induced dystonia | tetrabenazine-induced side effects | CLINICAL NEUROLOGY | Tourette's syndrome | Neurology | Encephalitis | Jaw | Young adults | Dopamine | Comorbidity | Pathogenesis | Tourette syndrome | Patients | Drug dosages | Age
Journal Article
BMJ - Clinical research, ISSN 0959-8138, 1999, Volume 319, Issue 7210, pp. 623 - 626
Journal Article
EUROPEAN JOURNAL OF PHARMACOLOGY, ISSN 0014-2999, 08/2000, Volume 401, Issue 2, pp. 155 - 160
Acute dystonic reactions are motor side effects that occur soon after the initiation of neuroleptic treatment. Although earlier studies indicate that these...
DRUG-INDUCED DYSTONIA | SCHIZOPHRENIC-PATIENTS | INTRAVENOUS METOCLOPRAMIDE | RISK FACTOR | GUINEA-PIG BRAIN | haloperidol | AUTORADIOGRAPHIC VISUALIZATION | LIGANDS | dystonia | ANTIPSYCHOTIC-DRUGS | extrapyramidal | PHARMACOLOGY & PHARMACY | neuroleptic | EXTRAPYRAMIDAL SYMPTOMS | sigma receptor | Binding, Competitive | Acute Disease | Prognosis | Dystonia - pathology | Humans | Rats | Male | Dystonia - metabolism | Rats, Sprague-Dawley | Brain - metabolism | Membranes - metabolism | Animals | Antipsychotic Agents - metabolism | Radioligand Assay | Receptors, sigma - metabolism
DRUG-INDUCED DYSTONIA | SCHIZOPHRENIC-PATIENTS | INTRAVENOUS METOCLOPRAMIDE | RISK FACTOR | GUINEA-PIG BRAIN | haloperidol | AUTORADIOGRAPHIC VISUALIZATION | LIGANDS | dystonia | ANTIPSYCHOTIC-DRUGS | extrapyramidal | PHARMACOLOGY & PHARMACY | neuroleptic | EXTRAPYRAMIDAL SYMPTOMS | sigma receptor | Binding, Competitive | Acute Disease | Prognosis | Dystonia - pathology | Humans | Rats | Male | Dystonia - metabolism | Rats, Sprague-Dawley | Brain - metabolism | Membranes - metabolism | Animals | Antipsychotic Agents - metabolism | Radioligand Assay | Receptors, sigma - metabolism
Journal Article
Otolaryngology–Head and Neck Surgery, ISSN 0194-5998, 10/1990, Volume 103, Issue 4, pp. 658 - 659
Journal Article
Acta Psychiatrica Scandinavica, ISSN 0001-690X, 12/1990, Volume 82, Issue 6, pp. 454 - 457
The Pisa syndrome is not yet well characterized, although there have been increasing reports on its prevalence and the clinical features of drug‐induced...
acute dystonia | cerebral lesion | Pisa syndrome | tardive dystonia | Tardive dystonia | Acute dystonia | Cerebral lesion | CEREBRAL LESION | PROPHYLAXIS | DRUG-INDUCED DYSTONIA | PISA SYNDROME | ACUTE DYSTONIA | PSYCHIATRY | TARDIVE DYSTONIA | NEUROLEPTICS | J VE PSYCHIATRY | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Schizophrenic Psychology | Syndrome | Posture | Antipsychotic Agents - administration & dosage | Intellectual Disability - drug therapy | Dyskinesia, Drug-Induced - classification | Orientation - drug effects | Gait - drug effects | Neurologic Examination | Adult | Female | Intellectual Disability - psychology | Aged | Antiparkinson Agents - administration & dosage | Schizophrenia - drug therapy | Dyskinesia, Drug-Induced - diagnosis
acute dystonia | cerebral lesion | Pisa syndrome | tardive dystonia | Tardive dystonia | Acute dystonia | Cerebral lesion | CEREBRAL LESION | PROPHYLAXIS | DRUG-INDUCED DYSTONIA | PISA SYNDROME | ACUTE DYSTONIA | PSYCHIATRY | TARDIVE DYSTONIA | NEUROLEPTICS | J VE PSYCHIATRY | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Schizophrenic Psychology | Syndrome | Posture | Antipsychotic Agents - administration & dosage | Intellectual Disability - drug therapy | Dyskinesia, Drug-Induced - classification | Orientation - drug effects | Gait - drug effects | Neurologic Examination | Adult | Female | Intellectual Disability - psychology | Aged | Antiparkinson Agents - administration & dosage | Schizophrenia - drug therapy | Dyskinesia, Drug-Induced - diagnosis
Journal Article
ANALES DEL SISTEMA SANITARIO DE NAVARRA, ISSN 1137-6627, 2008, Volume 31, pp. 127 - 140
Acute or sub-acute movement disorders represent a small percentage of neurological emergencies but it is necessary to be aware of their existence because a...
SEROTONIN SYNDROME | MANAGEMENT | drug induced dystonia | neuroleptic malignant syndrome | DYSTONIA-PARKINSONISM | emergencies in Parkinson's disease | LESIONS | STROKE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ADVANCED PARKINSONS-DISEASE | THERAPY | PSYCHOSIS | ENCEPHALITIS | serotonergic sindrome | OF-THE-LITERATURE | Dystonia - therapy | Parkinson Disease - therapy | Serotonin Syndrome - therapy | Acute Disease | Dystonia - diagnosis | Algorithms | Emergency Treatment | Movement Disorders - therapy | Humans | Movement Disorders - diagnosis | Serotonin Syndrome - diagnosis | Parkinson Disease - diagnosis
SEROTONIN SYNDROME | MANAGEMENT | drug induced dystonia | neuroleptic malignant syndrome | DYSTONIA-PARKINSONISM | emergencies in Parkinson's disease | LESIONS | STROKE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ADVANCED PARKINSONS-DISEASE | THERAPY | PSYCHOSIS | ENCEPHALITIS | serotonergic sindrome | OF-THE-LITERATURE | Dystonia - therapy | Parkinson Disease - therapy | Serotonin Syndrome - therapy | Acute Disease | Dystonia - diagnosis | Algorithms | Emergency Treatment | Movement Disorders - therapy | Humans | Movement Disorders - diagnosis | Serotonin Syndrome - diagnosis | Parkinson Disease - diagnosis
Journal Article
Journal of Emergency Medicine, ISSN 0736-4679, 1987, Volume 5, Issue 4, pp. 293 - 297
Four patients presented to the emergency department with acute dystonic reactions 36 hours after the ingestion of "Valium tablets" they purchased on the...
look-alike drugs | drug-induced dystonia | street drugs | acute dystonic reaction
look-alike drugs | drug-induced dystonia | street drugs | acute dystonic reaction
Journal Article
Biological Psychiatry, ISSN 0006-3223, 1997, Volume 41, Issue 10, pp. 1010 - 1019
Several antipsychotic drugs, belonging to various chemical classes, were compared for their affinity for the σ, dopamine-D , and muscarinic receptors. Many...
acute dystonia | neuroleptic/antipsychotic | cholinergic muscarinic receptors | σ receptors | dopaminergic D 2 receptors | receptors | dopaminergic D | SCHIZOPHRENIC-PATIENTS | HALOPERIDOL | PSYCHIATRY | INTRAVENOUS METOCLOPRAMIDE | GUINEA-PIG | EXTRAPYRAMIDAL REACTIONS | ANTIEMETIC THERAPY | NEUROSCIENCES | K RU NEUROSCIENCES | K VE PSYCHIATRY | sigma receptors | INDUCED EMESIS | SEROTONIN ANTAGONIST | dopaminergic D-2 receptors | ANTIPSYCHOTIC-DRUGS | OPIATE RECEPTORS | Antipsychotic Agents - toxicity | Receptors, sigma - drug effects | Dyskinesia, Drug-Induced - physiopathology | Rats, Wistar | Dopamine Agonists - pharmacokinetics | Rats | Male | Receptors, sigma - physiology | Antipsychotic Agents - pharmacokinetics | Dyskinesia, Drug-Induced - pathology | Spiperone - pharmacokinetics | Animals | Receptors, Muscarinic - drug effects | Receptors, Dopamine D2 - drug effects | Piperidines - pharmacokinetics | Receptors, Dopamine D2 - physiology | Quinuclidinyl Benzilate - pharmacokinetics | Radioligand Assay | Receptors, Muscarinic - physiology
acute dystonia | neuroleptic/antipsychotic | cholinergic muscarinic receptors | σ receptors | dopaminergic D 2 receptors | receptors | dopaminergic D | SCHIZOPHRENIC-PATIENTS | HALOPERIDOL | PSYCHIATRY | INTRAVENOUS METOCLOPRAMIDE | GUINEA-PIG | EXTRAPYRAMIDAL REACTIONS | ANTIEMETIC THERAPY | NEUROSCIENCES | K RU NEUROSCIENCES | K VE PSYCHIATRY | sigma receptors | INDUCED EMESIS | SEROTONIN ANTAGONIST | dopaminergic D-2 receptors | ANTIPSYCHOTIC-DRUGS | OPIATE RECEPTORS | Antipsychotic Agents - toxicity | Receptors, sigma - drug effects | Dyskinesia, Drug-Induced - physiopathology | Rats, Wistar | Dopamine Agonists - pharmacokinetics | Rats | Male | Receptors, sigma - physiology | Antipsychotic Agents - pharmacokinetics | Dyskinesia, Drug-Induced - pathology | Spiperone - pharmacokinetics | Animals | Receptors, Muscarinic - drug effects | Receptors, Dopamine D2 - drug effects | Piperidines - pharmacokinetics | Receptors, Dopamine D2 - physiology | Quinuclidinyl Benzilate - pharmacokinetics | Radioligand Assay | Receptors, Muscarinic - physiology
Journal Article
American Journal of Therapeutics, ISSN 1075-2765, 03/2008, Volume 15, Issue 2, pp. 184 - 186
Drug-induced movement disorders are commonly seen in the inpatient setting and outpatient movement disorders centers. The most common acute reactions are...
Drug induced | Foscarnet | Dystonia | PHARMACOLOGY & PHARMACY | drug induced | THERAPY | foscarnet | dystonia | Cytomegalovirus | Dystonia - chemically induced | Acute Disease | Antiviral Agents - therapeutic use | Foscarnet - adverse effects | Humans | Middle Aged | Diphenhydramine - therapeutic use | Viremia - drug therapy | Dystonia - drug therapy | Antiviral Agents - adverse effects | Female | Foscarnet - therapeutic use | Cholinergic Antagonists - therapeutic use | Index Medicus
Drug induced | Foscarnet | Dystonia | PHARMACOLOGY & PHARMACY | drug induced | THERAPY | foscarnet | dystonia | Cytomegalovirus | Dystonia - chemically induced | Acute Disease | Antiviral Agents - therapeutic use | Foscarnet - adverse effects | Humans | Middle Aged | Diphenhydramine - therapeutic use | Viremia - drug therapy | Dystonia - drug therapy | Antiviral Agents - adverse effects | Female | Foscarnet - therapeutic use | Cholinergic Antagonists - therapeutic use | Index Medicus
Journal Article
Neuropsychiatric Disease and Treatment, ISSN 1178-2021, 02/2016, Volume 2016, Issue Issue 1, pp. 497 - 499
Piotr Janik,1 Monika Figura1,2 1Department of Neurology, Anna Gostynska Wolski Hospital, 2Department of Neurology, Faculty of Health Sciences, Medical...
acute dystonia | dystonic tics | Tetrabenazine | Tourette syndrome | oculogyric crisis
acute dystonia | dystonic tics | Tetrabenazine | Tourette syndrome | oculogyric crisis
Journal Article
International Journal of Neuropsychopharmacology, ISSN 1461-1457, 02/2014, Volume 17, Issue 2, pp. 341 - 342
The prevailing opinion is that PDSS was caused by a large release of olanzapine to the blood stream immediately after the application of the injection....
PHARMACOLOGY & PHARMACY | PSYCHIATRY | NEUROSCIENCES | CLINICAL NEUROLOGY | Dystonia - psychology | Severity of Illness Index | Dystonia - chemically induced | Acute Disease | Antipsychotic Agents - adverse effects | Humans | Paliperidone Palmitate | Male | Young Adult | Dystonia - diagnosis | Akathisia, Drug-Induced - psychology | Akathisia, Drug-Induced - diagnosis | Palmitates - adverse effects | Isoxazoles - adverse effects | Psychotropic drugs | Delirium | Schizophrenia | Anesthesia | Hospitalization | Intubation
PHARMACOLOGY & PHARMACY | PSYCHIATRY | NEUROSCIENCES | CLINICAL NEUROLOGY | Dystonia - psychology | Severity of Illness Index | Dystonia - chemically induced | Acute Disease | Antipsychotic Agents - adverse effects | Humans | Paliperidone Palmitate | Male | Young Adult | Dystonia - diagnosis | Akathisia, Drug-Induced - psychology | Akathisia, Drug-Induced - diagnosis | Palmitates - adverse effects | Isoxazoles - adverse effects | Psychotropic drugs | Delirium | Schizophrenia | Anesthesia | Hospitalization | Intubation
Journal Article
American Journal of Therapeutics, ISSN 1075-2765, 2014, Volume 21, Issue 2, pp. e38 - e40
Ziprasidone is a second-generation antipsychotic with a lower propensity to cause extrapyramidal adverse effects that are seen at higher doses. We report a...
Parkinsonism | Acute dystonia | Akathisia | Atypical antipsychotic | Ziprasidone | acute dystonia | AGENT | parkinsonism | SERTRALINE | OVERDOSE | akathisia | SCHIZOPHRENIA | PHARMACOLOGY & PHARMACY | ziprasidone | atypical antipsychotic | BIPOLAR DISORDER | Piperazines - administration & dosage | Dystonia - chemically induced | Acute Disease | Antipsychotic Agents - adverse effects | Humans | Male | Thiazoles - administration & dosage | Parkinsonian Disorders - chemically induced | Piperazines - adverse effects | Thiazoles - adverse effects | Antipsychotic Agents - administration & dosage | Dose-Response Relationship, Drug | Adult | Akathisia, Drug-Induced - etiology
Parkinsonism | Acute dystonia | Akathisia | Atypical antipsychotic | Ziprasidone | acute dystonia | AGENT | parkinsonism | SERTRALINE | OVERDOSE | akathisia | SCHIZOPHRENIA | PHARMACOLOGY & PHARMACY | ziprasidone | atypical antipsychotic | BIPOLAR DISORDER | Piperazines - administration & dosage | Dystonia - chemically induced | Acute Disease | Antipsychotic Agents - adverse effects | Humans | Male | Thiazoles - administration & dosage | Parkinsonian Disorders - chemically induced | Piperazines - adverse effects | Thiazoles - adverse effects | Antipsychotic Agents - administration & dosage | Dose-Response Relationship, Drug | Adult | Akathisia, Drug-Induced - etiology
Journal Article
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 04/2013, Volume 33, Issue 2, pp. 269 - 270
Dystonia - chemically induced | Acute Disease | Antipsychotic Agents - adverse effects | Humans | Parkinsonian Disorders - chemically induced | Piperazines - therapeutic use | Aripiprazole | Bipolar Disorder - drug therapy | Piperazines - adverse effects | Quinolones - adverse effects | Antipsychotic Agents - therapeutic use | Quinolones - therapeutic use | Adult | Female | Akathisia, Drug-Induced - etiology
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.